Data News > BD Exceeds Q3 Earnings Expectations, Sees Margin Growth
- Becton, Dickinson and Company (BDX) surpasses earnings estimates in fiscal third quarter
- Revenue growth seen in all segments leading to overall positive top-line performance
- Strong demand for drug-delivery devices contributes to better-than-expected profit
- BD reports strong financial results with revenue of $5.0 billion and adjusted EPS of $3.50
- Company updates fiscal 2024 revenue and EPS guidance, showing confidence in future performance
BD (BDX) exceeded expectations in their third quarter earnings report for fiscal 2024, showcasing solid performance across all segments. The company's overall revenue saw growth, leading to positive top-line results. Becton, Dickinson and Company (BDX) held their Q3 2024 Earnings Conference Call on August 1, 2024, with key company executives discussing the results.
During the earnings call, Becton, Dickinson and Company (BDX) reported earnings of $3.50 per share, surpassing the Zacks Consensus Estimate of $3.31 per share. This marked a significant improvement from the $2.96 per share reported in the same quarter last year. The strong performance was driven by increased demand for the company's drug-delivery devices.
BD's third quarter financial results highlighted a robust margin execution, with reported revenue reaching $5.0 billion and adjusted revenue hitting $5.1 billion. The company also saw growth in both GAAP and adjusted diluted EPS, with a 23.5% and 18.2% increase, respectively. Cash from Continuing Operations surged by 60% year-to-date, reaching $2.7 billion, while Free Cash Flow more than doubled to $2.2 billion.
Looking ahead, Becton, Dickinson and Company (BDX) updated its fiscal 2024 guidance, expecting a GAAP revenue growth of approximately 3.7% and organic revenue growth ranging from 5.0% to 5.25%. The company also revised its adjusted diluted EPS guidance, raising it by 5 cents at the midpoint to $13.05 to $13.15. These updates indicate the company's confidence in its continued growth and performance in the upcoming year.
Overall, BD's third quarter results surpassing estimates, strong margin execution, and positive outlook for future revenue and EPS growth demonstrate a solid performance by the company in the face of economic challenges.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
BD Exceeds Q3 Earnings Expectations, Sees Margin Growth
By KlickAnalytics Data Insights | August 1, 2024 08:09PM ET
Key Points
- Becton, Dickinson and Company (BDX) surpasses earnings estimates in fiscal third quarter
- Revenue growth seen in all segments leading to overall positive top-line performance
- Strong demand for drug-delivery devices contributes to better-than-expected profit
- BD reports strong financial results with revenue of $5.0 billion and adjusted EPS of $3.50
- Company updates fiscal 2024 revenue and EPS guidance, showing confidence in future performance
BD (BDX) exceeded expectations in their third quarter earnings report for fiscal 2024, showcasing solid performance across all segments. The company's overall revenue saw growth, leading to positive top-line results. Becton, Dickinson and Company (BDX) held their Q3 2024 Earnings Conference Call on August 1, 2024, with key company executives discussing the results.
During the earnings call, Becton, Dickinson and Company (BDX) reported earnings of $3.50 per share, surpassing the Zacks Consensus Estimate of $3.31 per share. This marked a significant improvement from the $2.96 per share reported in the same quarter last year. The strong performance was driven by increased demand for the company's drug-delivery devices.
BD's third quarter financial results highlighted a robust margin execution, with reported revenue reaching $5.0 billion and adjusted revenue hitting $5.1 billion. The company also saw growth in both GAAP and adjusted diluted EPS, with a 23.5% and 18.2% increase, respectively. Cash from Continuing Operations surged by 60% year-to-date, reaching $2.7 billion, while Free Cash Flow more than doubled to $2.2 billion.
Looking ahead, Becton, Dickinson and Company (BDX) updated its fiscal 2024 guidance, expecting a GAAP revenue growth of approximately 3.7% and organic revenue growth ranging from 5.0% to 5.25%. The company also revised its adjusted diluted EPS guidance, raising it by 5 cents at the midpoint to $13.05 to $13.15. These updates indicate the company's confidence in its continued growth and performance in the upcoming year.
Overall, BD's third quarter results surpassing estimates, strong margin execution, and positive outlook for future revenue and EPS growth demonstrate a solid performance by the company in the face of economic challenges.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.